DENTSPLY Sirona Inc (XRAY) concluded trading on Thursday at a closing price of $17.15, with 6.16 million shares of worth about $105.66 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -32.16% during that period and on February 27, 2025 the price saw a loss of about -8.83%. Currently the company’s common shares owned by public are about 198.80M shares, out of which, 197.55M shares are available for trading.
Stock saw a price change of -9.50% in past 5 days and over the past one month there was a price change of -12.59%. Year-to-date (YTD), XRAY shares are showing a performance of -9.64% which decreased to -49.09% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $17.21 but also hit the highest price of $34.91 during that period. The average intraday trading volume for DENTSPLY Sirona Inc shares is 2.53 million. The stock is currently trading -9.14% below its 20-day simple moving average (SMA20), while that difference is down -9.31% for SMA50 and it goes to -25.84% lower than SMA200.
DENTSPLY Sirona Inc (NASDAQ: XRAY) currently have 198.80M outstanding shares and institutions hold larger chunk of about 102.67% of that.
The stock has a current market capitalization of $3.41B and its 3Y-monthly beta is at 0.97. It has posted earnings per share of -$2.07 in the same period. It has Quick Ratio of 0.84 while making debt-to-equity ratio of 0.93. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for XRAY, volatility over the week remained 4.72% while standing at 3.10% over the month.
Stock’s fiscal year EPS is expected to rise by 10.09% while it is estimated to increase by 11.28% in next year. EPS is likely to shrink at an annualized rate of 11.91% for next 5-years, compared to annual growth of 32.70% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wells Fargo on February 14, 2025 offering an Equal weight rating for the stock and assigned a target price of $20 to it. Coverage by Jefferies stated DENTSPLY Sirona Inc (XRAY) stock as a Hold in their note to investors on January 23, 2025, suggesting a price target of $20 for the stock. On January 07, 2025, Evercore ISI Downgrade their recommendations, while on December 04, 2024, Mizuho Initiated their ratings for the stock with a price target of $21. Stock get a Market perform rating from Leerink Partners on November 07, 2024.
